Physician profile
Asata Kamara
NPI 1124412788
$1,893.78
in general payments reported to CMS, 2019-2025
18 companies · $37.05 in 2025
The $37.05 reported for 2025 was less than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,524 · 2022: $176 · 2023: $133 · 2024: $23.56 · 2025: $37.05.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $193.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $193.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $441.13 | 2021-2025 | |
| Novo Nordisk INC | $305.96 | 2021-2023 | Ozempic, Rybelsus |
| Esperion Therapeutics, INC. | $226.62 | 2021 | |
| Lilly USA, LLC | $193.46 | 2021 | |
| Abbott Laboratories | $155.26 | 2021-2025 | Freestyle Libre 2, Freestyle Libre 3 |
| Bayer Healthcare Pharmaceuticals INC. | $94.27 | 2021-2022 | |
| Corcept Therapeutics | $84.61 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $73.20 | 2021 | |
| Merck Sharp & Dohme LLC | $61.68 | 2021 | |
| Eisai INC. | $51.34 | 2021 | |
| Pfizer INC. | $41.99 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $33.24 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $29.82 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $24.18 | 2021 | |
| Hologic Sales and Service, LLC | $23.56 | 2024 | Aptima |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $18.22 | 2021 | |
| Novartis Pharmaceuticals Corporation | $17.70 | 2022 | |
| Glaxosmithkline, LLC. | $17.54 | 2023 | Trelegy Ellipta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Asata Kamara listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.